22 results
424B3
TRML
Tourmaline Bio Inc
15 Sep 23
Prospectus supplement
6:31am
, the manufacturing facility or Talaris, including requiring recall or withdrawal of the product from the market or suspension of manufacturing … or export of products, or require Talaris to initiate a product recall.
Should Talaris resume the development of biopharmaceutical product
S-4/A
jt7h21poo 7yw8
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
zgn0u10yja 44
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
10-K
hlndxhs vegd
17 Mar 22
Annual report
4:31pm
10-Q
nq8si
14 Jun 21
Quarterly report
4:21pm
424B4
151xd5x
10 May 21
Prospectus supplement with pricing info
4:20pm
S-1/A
2bggu4wsa2 jh
3 May 21
IPO registration (amended)
6:07am